Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons?
Angioletta LasagnaValentina ZuccaroPaolo SacchiSilvia ChiellinoRaffaele BrunoPaolo PedrazzoliPublished in: Future oncology (London, England) (2021)
Keyphrases